Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Fibrosis and ABCB1[original query] |
|---|
| Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. Journal of clinical pharmacology 2008 Aug 48 (8): 957-65. Liu Shanshan, Beringer Paul M, Hidayat Levita, Rao Adupa P, Louie Stan, Burckart Gilbert J, Shapiro Bertra |
| Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. Journal of the American Society of Nephrology : JASN 2009 Nov 20 (11): 2468-80. Naesens Maarten, Lerut Evelyne, de Jonge Hylke, Van Damme Boudewijn, Vanrenterghem Yves, Kuypers Dirk R |
| The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients. Clinical transplantation 2014 May 28 (5): 590-7. Schoeppler Kelly E, Aquilante Christina L, Kiser Tyree H, Fish Douglas N, Zamora Martin |
| Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients. Pharmacogenomics 2014 Dec 15 (16): 2011-24. Bloch Julie, Hazzan Marc, Van der Hauwaert Cynthia, Buob David, Savary Grégoire, Hertig Alexandre, Gnemmi Viviane, Frimat Marie, Perrais Michaël, Copin Marie-Christine, Broly Franck, Noël Christian, Pottier Nicolas, Cauffiez Christelle, Glowacki Franço |
| Case report: Hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023? Frontiers in pharmacology 2023 5 14 1130548. Ali El Rida El Masri, Caroline Tobler, Breunis Willemijn, Andre O Von Bueren, Marc Ansari, Caroline Flora Sam |
- Page last reviewed:Feb 1, 2024
- Content source: